Alton EWFW, Armstrong DK, Ashby D, et al, on behalf of the UK Cystic Fibrosis Gene Therapy Consortium. Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial. Lancet Respir Med 2015; published online July 3. http://dx.doi.org/10.1016/S2213-2600(15)00245-3—In this Article, Catherine McKenny (Oxford Churchill) was missing from the Acknowledgments, as was reference to financial support from NHS Research Scotland, through the Edinburgh Clinical Research Facility. This correction has been made to the online version as of Sept 7, 2015, and the printed version is correct.
. 2015 Sep;3(9):e33. doi: 10.1016/S2213-2600(15)00314-8
Corrections
© 2015 Alton et al. Open Access article distributed under the terms of CC BY
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).
PMCID: PMC5603775 PMID: 26380890
This corrects the article "Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial" on page 684.